Skip to main content
. 2011 Jul 15;89(1):56–66. doi: 10.1016/j.ajhg.2011.05.027

Table 1.

Summary of Clinical Data for Some of the Affected Individuals of Family HN-W078

Patient Gender Age (Years)
Use of Aminoglycoside Hearing Test PTA(dB HL)
Audiogram Shape Level of Hearing Impairment Vertigo Tinnitus
At Testing At Onset Left Ear Right Ear
II:7 female 76 24 no 80 88 flat severe no yes
III:10 male 60 22 no 79 80 flat severe no yes
III:13 male 59 26 no 110 76 flat severe no yes
III:15 female 53 20 no 66 66 flat moderate no yes
III:19 female 52 30 no 60 62 flat moderate no no
IV:3 male 52 24 no 61 68 flat moderate no yes
IV:6 male 49 24 no 63 64 flat moderate no yes
IV:8 male 40 23 no 71 71 flat severe no no
IV:10 male 55 20 no 76 78 flat severe no yes
IV:24 male 30 15 no 70 70 flat severe no yes
IV:26 female 26 20 no 58 55 sloping moderate no yes
IV:31 male 18 12 no 48 48 flat moderate no yes
IV:33 male 33 26 no 60 69 flat moderate no yes
IV:35 female 31 20 no 58 59 flat moderate no yes
V:13 male 27 23 no 53 54 sloping moderate no no
V:27 female 23 16 no 41 44 flat moderate no no

The degree of hearing loss was defined according to pure-tone averages (PTAs), which were based on the frequencies 500, 1,000, and 2,000 Hz.